

Author: Plosker G.L. Noble S.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.58, Iss.2, 1999-08, pp. : 325-345
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cidofovir cost saving for AIDS-related CMV retinitis
Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. :


Cidofovir cost saving for AIDS-related CMV retinitis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. :



